
Topic
Oncology
HER2-targeted therapy, tumor-type access, buy-and-bill reimbursement, oncology biosimilars, and cancer drug coverage.

Pricing & Access· May 31, 2026 · 12 min read

Pricing & Access· May 31, 2026 · 12 min read
Renewal denial after stable disease: documenting continued benefit

Pipeline· May 30, 2026 · 11 min read
ASCO 2026 practice-changing results with formulary implications

Pricing & Access· May 30, 2026 · 11 min read
Datroway TNBC coverage guide: TROP2 ADC access and coding
By Ran Chen#ADC#Breast Cancer#Prior Authorization

Pricing & Access· May 29, 2026 · 10 min read
Tecentriq Hybreza bladder cancer MRD access guide
By Ran Chen#Oncology#PD-L1#Companion Diagnostic

Approvals· May 28, 2026 · 7 min read
Beqalzi coverage guide: sonrotoclax access in mantle cell lymphoma

Approvals· May 28, 2026 · 7 min read
Decnupaz coverage guide: pivekimab sunirine access in BPDCN

Pipeline· May 27, 2026 · 7 min read
Antibody-drug conjugate access landscape: ADC coverage and pipeline watch
By Ran Chen#ADC#HER2#Prior Authorization

Pipeline· May 27, 2026 · 7 min read
ASCO 2026 pipeline evidence preview for formulary and access teams

Pricing & Access· May 27, 2026 · 12 min read
Enhertu coverage guide: HER2 testing, PA criteria, and patient support
By Ran Chen#Oncology#Prior Authorization#Payer Policy